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ABSTRACT
Cigarette smoking is a major cause of cardiovascular disease due to elevation of free 
radical substances as well impairment in lipid metabolism. Smoking cesation has been 
linked with reduced risk of mortality. However, data regarding cardiovascular disease 
(CVD) risk factor in former smoker is limited. The aim of the study was  to evaluate the 
CVD risk factor among smoker, non-smoker and former smoker in Yogyakarta Special 
Region, Indonesia. A cross-sectional design from 86 apparently healthy male, aged 
between 25-50 years old was performed for this study. From total subjects, 45 subjects 
are smokers, 26 are non-smokers and 15 are former smokers. Body weight, height, and 
blood pressure were also measured from the subjects. Blood was drawn for assessment of 
total cholesterol (TC), triglyceride, low density lipoprotein (LDL), high density lipoprotein 
(HDL) and C-reactive protein (CRP) concentrations.  We found significant difference in 
the level of HDL, cardiovascular risk index (LDL/HDL ratio), atherogenic index (TC/HDL 
ratio) and also in systolic blood pressure among groups (p<0.05). Smoking person had 
significantly low HDL level with high CVD risk index and atherogenic index (p<0.05). 
The CVD risk index was not different between former smoker and smoker groups. Serum 
CRP level was not different  among the groups.  In conclusion, smoking is associated with 
increased risk of CVD. Smoking cessation slightly decrease the CVD risk.
ABSTRAK
Merokok merupakan penyebab utama penyakit kardiovaskuler akibat kenaikan radikal bebas 
dan gangguan metabolisme lipid. Berhenti merokok dihubungkan dengan menurunnya 
risiko kemation. Namun demikian, data mengenai faktor risiko  penyakit kardiovaskuler 
mantan perokok sangat terbatas. Penelitian ini bertujuan mengkaji faktor risiko penyakit 
kardiovaskuler diantara perokok, bukan perokok dan mantan perokok di Daerah Istimewa 
Yogyakarta, Indonesia. Penelitian dengan rancangan potong lintang terhadap 86 lelaki 
sehat secara klinis, berumur 25-50 tahun dilakukan dalam penelitian ini. Dari total 86 
subjek, 45 merupakan perokok, 26 bukan perokok dan 15 mantan perokok. Berat badan, 
tinggi badan dan tekanan darah juga dimonitor dalam penelitian. Sampel darah diambil 
untuk pemeriksaan kadar kolesterol total, trigliserida, low density lipoprotein (LDL), high 
density lipoprotein (HDL) and protein C-reaktif (CRP). Perbedaan nyata ditemukan dalam 
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kadar HDL, indeks risiko kardiovaskuler (rasio LDL/HDL), indeks atherogenic (rasio TC/
HDL) dan juga tekanan darah diantara kelompok subjek (p<0,05). Perokok mempunyai 
kadar HDL lebih rendah secara nyata dengan indeks risiko kardiovaskuler tinggi dan indeks 
atherogenic tinggi (p<0,05).  Indeks risiko menderita penyakit kardiovaskuler  antara 
mantan perokok dan perokok tidak berbeda nyata. Kadar CRP serum tidak berbeda nyata 
antar keompok (p>0,05). Kesimpulan, merokok berhubungan dengan meningkatna risiko 
menderita penyakit kardiovakuler. Berhenti merokok dapat sedikit mengurangi risiko 
penyakit kardiovaskuler. 
Keywords: Cigarette smoking - cardiovascular disease – C-reactive protein - lipid profile 
- atherogenic index 
INTRODUCTION 
Cigarette smoking is the most major 
significance cause of death worldwide. It 
was estimated that 20% of death of adult 
men and 5% of death of adult women were 
attributed to the use of tobaco smoking. In 
addition, approximately 450 million adults 
aged between 30 and 69 years old were killed 
in the last 5 decades.1,2 The majority of these 
death occur in the economically developing 
countries where the regulation and taxes 
regarding cigarette smoking is loosen.1 
Moreover, smoking causes over US$ 500 
billion in economic loss annually.3 
Indonesia is one of the smoker high 
prevalence countries in Southeast Asia with 
prevalence of 35.7%.4,5 Early exposure to 
cigarette smoking due to environmental 
factors are associated with the high prevalence 
of cigarette smoking in Indonesia.6 If action 
is not taken, more adult people will be killed 
by smoking-related disease particularly lung 
cancer7  and cardiovascular disease (CVD).8 
High exposure of free radicals derived from 
cigarette smoke (the tar and the gas phase) 
has been proposed as the mechanism between 
smoking and CVD development.9 High free 
radical derived from cigarette smoke activates 
intracellular signaling cascades that promotes 
chronic immune cell recruitment and 
inflammation through activation of several 
inflammatory gene, e.g. interleukin (IL)-8 and 
tumor necrosis factor-α (TNF-α).10-12
C-reactive protein (CRP) is an acute phase 
protein, which is synthesized in response to 
systemic inflammation. It is associated with 
the progression of CVD event13  as well in 
malignancies development.14,15 Increased 
in CRP level as a result of tissue injury has 
been observed in smoking person even after 
cessation of cigarette smoking, indicating 
the high risk of CVD in former smoker.16 
Although CRP is not the only sole predictor 
of CVD event in smoker, however, CRP level 
in the blood is positively correlated with 
reactive oxygen metabolites.17,18 The high 
reactive oxygen metabolites in the blood 
may accelerate the progression of plaque 
formation through the formation of oxidized-
LDL.19  In addition, low HDL level has also 
been observed in cigarette smoker, which will 
aggravate the formation of oxidized-LDL.20 
Cessation of cigarette smoking has been 
associated with increased size and particle of 
HDL.21 However, data regarding the CVD risk 
of former smoker is limited. This study was 
performed to evaluate the CVD risk factor in 
smoker, non-smoker and former smoker in 
Yogyakarta Special Region, Indonesia.            
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MATERIALS AND METHODS 
Study design and subjects 
A cross sectional study was performed 
between May-June 2015 using multistage 
cluster random sampling throughout 23 
districts in Yogyakarta Special Region. Data 
were collected based on the inclusion criteria 
as follow: male, aged between 25 to 50 years 
old, did not diagnosed with chronic disease, 
reside in the Yogyakarta Special Region 
for over 5 years, and willing to be a subject 
proofed by filling the informed consent form. 
Eighty six (86) subjects that comprised by 
45 current smokers, 15 former smokers and 
26 non-smokers were sucessfully recruited 
in this study. Former smoker was defined as 
person who quit smoking for more than 1 year. 
Subjects were subjected to 8 hour fast prior 
to blood drawn. The study protocol has been 
approved by the Medical and Health Research 
Ethics Committee,  Faculty of Medicine, 
Universitas Gadjah Mada, Yogyakarta, 
Indonesia (No. KE/FK/665/EC/2015). 
 
Biochemical analysis  
After signed an informed consent, 
subjects were subjected to an 8 hours fasting. 
Approximately, 8 mL of blood sample was 
drawn and centrifuged briefly to obtain serum. 
Serum was then stored in -20° C until analysis 
or analyzed directly for total cholesterol, 
triglyceride, LDL, HDL and serum CRP 
levels. Total cholesterol and triglycerides 
were analysized using enzymatic colorimetris 
method using cholesterol test kit (cholesterol 
FS, Diasys, Germany) and triglyceride test kit 
(triglyceride FS, Dyasis, Germany) according 
to manufacturer protocol.  LDL and HDL were 
precipitated first prior to the analysis using 
HDL and LDL cholesterol test kit (Dyasis, 
Germany). Serum CRP level was analyzed 
using human CRP ELISA kit (Thermo Fisher 
Scientific, USA) according to manufacturer 
protocol. Body weight was measured using 
digital scale (Camry) in minimal clothes. 
Height and blood pressure were measured 
using standardized procedure. Body mass 
index (BMI) was calculated based on body 
weight and body height. All measurement 
were performed in triplicates.  
Statistical analysis 
Data were presented as mean ± standard 
deviation (SD) and analyzed using one way 
analysis of variance (ANOVA) followed by 
student t-test. All data analysis were performed 
in SPSS version 20 (IBM, USA). A p value < 
0.05 was considered significant. 
RESULTS
No significantly different between age, 
body weight, height, BMI and distolic blood 
pressure among smoker, former smoker and 
non-smoker were observed in this study 
(TABLE 1). It was indicated that subjects had 
similar characteristic between group although 
the systolic blood pressure was found to be 
significantly different among groups (p<0.05).
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TABLE 1. Baseline characteristics of subjects
Variables
Status (mean ± SD)
p
Smoker Former smoker Non-smoker
Age (year) 39.33±5.70 42.07±6.08 40.94±6.61 0.262
Body Weight (kg) 66.54±10.93 68.77±13.12 68.81±13.46 0.691
Height (cm) 164.62±6.52 161.33±4.79 165.30±5.22 0.102
BMI (kg/m2) 24.49±3.40 26.52±5.44 25.06±4.00 0.243
Systole 114.00±15.51 122.67±19.89 122.69±13.73 0.045
Diastole 77.56±11.85 77.67±12.94 82.31±10.51 0.232
No significantly different in total choleste-
rol, triglyceride, and LDL between smoker, 
former smoker and non-smoker were observed 
in this study (TABLE 2). However, the total 
cholesterol and triglyceride of smoker tended 
to be higher than former smoker and non 
smoker (p>0.05). In contrast, the HDLlevels 
were found to be significantly different among 
group with the lowest level was observed in 
smoker group (p<0.05). Furthermore, LDL/
HDL and total cholesterol/HDL ratio in smoker 
group were significantly higher than in former 
smoker and non smoker (p<0.05).  The serum 
CRP level of non-smoker was lower than that 
formal smoker and smoker. However, it was 
not significantly different (p> 0.05).
TABLE 2. Lipid profile and CRP level in smoker, former smoker and non-smoker groups 
Variables
Status (mean ± SD)
p
Smoker Former smoker Non-smoker
Total cholesterol (mg/dL) 205.91±37.60 198.80±30.86 189.92±36.11 0.203
Triglycerides (mg/dL) 208.04±159.01 138.40±70.96 150.73±98.15 0.094
LDL (mg/dL) 131.56±34.97 135.33±29.15 120.88±32.40 0.313
HDL (mg/dL) 38.82±7.29 43.13±6.93 42.88±7.24 0.033
LDL/HDL ratio 3.44±0.82ab 3.20±0.78bc 2.87±0.79c 0.019
TC/HDL ratio 5.45±1.18a 4.69±0.92b 4.52±0.99b 0.002
CRP (mg/L) 3.25±5.15 2.44±3.55 1.79±1.27 0.965
a,b,c: different notation indicated significantly different (p<0.05)  
DISCUSSION
Smoking is the most significance cause 
of CVD in the world. Smoking has been 
associated with 3 to 5.6 times risk of acute 
myocardial infarctions than non-smoker in 
similar age.22,23 Smoking cesation has been 
associated with 36% reduction in crude relative 
risk (RR) of mortality as well 32% reduction 
in non-fatal myocardial infarction.24,25 The 
reduction in CVD mortality by smoking 
cessation is caused by improvement in lipid 
profile (elevated level of HDL with reduced 
level of LDL).21,26,27 as well in reduced 
systemic inflammation marker IL-6.28 
In our study, no significantly different 
in serum CRP level between smoker, 
former smoker and non-smoker due to the 
high biological variability (high standard 
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deviation) was observed. This result was 
also observed in other studies.16,28,29 However, 
although statistically the serum CRP level 
was not significantly different, it tended to be 
higher in smoker compared to former smoker 
and non-smoker. It was indicated smoker is 
still in higher inflammation state. Our study 
observed approximately 25% lower in serum 
CRP level in former smoker indicating better 
inflammation status when cigarette smoking 
was ceased. 
We observed a significant higher level of 
HDL-cholesterol in former smoker and non-
smoker compared with smoker, which, again, 
indicated the beneficial effect of smoking 
cessation in ameliorating CVD risk through 
elevation of HDL level. We did not find any 
difference in the level of total cholesterol, 
triglyceride, and LDL level among the groups 
that was similar with previous studies.21,30  We 
also observed a reduction in CVD risk index 
and total/HDL cholesterol ratio or Castelli 
index in former smoker compared with smoker 
although the level of LDL/HDL ratio was not 
significantly different compared to that the 
smoker group. Total/high-density lipoprotein 
(HDL) cholesterol and LDL/HDL cholesterol 
ratios are risk indicators with greater 
predictive value than LDL or HDL alone.31,32 
A ratio LDL/HDL of 2.3 to 2.5 can predict the 
CVD risk factors in the population.32,33
CONCLUSION
In conclusion, smoking cessation is 
associated with the reduce of total cholesterol/
HDL cholesterol ratio on adult people 
indicating the reduce of CVD risk. 
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